Compounds, formulations, and methods for treating or...

Details Compounds, formulations, and methods for treating or... Compounds, formulations, and methods for treating or...

2004-05-25

2008-10-21

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S401000, C514S649000, C514S651000

Reexamination Certificate

active

07439241

ABSTRACT:
In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below:wherein each of R1, R2, and R3is independently hydrogen, hologen, alkyl, or alkoxy;each of R4and R5is independently hydrogen, alkyl, or alkoxy; and each of R6and R7is independently hydrogen, nitro, alkyl, or alkoxy;wherein each of A1, A3, and A4is independently hydrogen or alkyl; and A2is independently hydrogen or hydroxy; andwherein each of B1, B2, and B3is independently hydrogen, hydroxy, or alkoxy; and each of B4and B5is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.

REFERENCES:
patent: 3560501 (1971-02-01), Walker
patent: 3594380 (1971-07-01), Sulkowski
patent: 3723432 (1973-03-01), Ott
patent: 3736297 (1973-05-01), Bracke
patent: 3740442 (1973-06-01), Ott
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4029792 (1977-06-01), Danielewicz et al.
patent: 4164570 (1979-08-01), Clough et al.
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4285967 (1981-08-01), Gubernick et al.
patent: 5021416 (1991-06-01), Gluchowski
patent: 5077292 (1991-12-01), Gluchowski
patent: 5112822 (1992-05-01), Gluchowski
patent: 5130441 (1992-07-01), Gluchowski
patent: 5198442 (1993-03-01), Gluchowski
patent: 5204347 (1993-04-01), Gluchowski
patent: 5237072 (1993-08-01), Gluchowski
patent: 5300504 (1994-04-01), Gluchowski
patent: 5326763 (1994-07-01), Gluchowski et al.
patent: 5373010 (1994-12-01), Gluchowski et al.
patent: 5418234 (1995-05-01), Gluchowski et al.
patent: 5424078 (1995-06-01), Dziabo et al.
patent: 5442053 (1995-08-01), Della Valle et al.
patent: 5552403 (1996-09-01), Burke et al.
patent: 5561132 (1996-10-01), Burke et al.
patent: 5587376 (1996-12-01), Burke et al.
patent: 5693646 (1997-12-01), Jones et al.
patent: 5696127 (1997-12-01), Jones et al.
patent: 5703077 (1997-12-01), Burke et al.
patent: 5714486 (1998-02-01), Burke et al.
patent: 5720962 (1998-02-01), Ivy et al.
patent: 5721237 (1998-02-01), Myers et al.
patent: 5736165 (1998-04-01), Ripley et al.
patent: 5753637 (1998-05-01), Fried
patent: 5756503 (1998-05-01), Burke et al.
patent: 5773440 (1998-06-01), Burke et al.
patent: 6117871 (2000-09-01), Maurer et al.
patent: 6117877 (2000-09-01), Fogel
patent: 6194415 (2001-02-01), Wheeler et al.
patent: 6248741 (2001-06-01), Wheeler et al.
patent: 6284765 (2001-09-01), Caffrey
patent: 6294553 (2001-09-01), Gil et al.
patent: 6323204 (2001-11-01), Burke et al.
patent: 6432934 (2002-08-01), Gilbard
patent: 6441047 (2002-08-01), Desantis, Jr.
patent: 6444681 (2002-09-01), Flavahan et al.
patent: 6465464 (2002-10-01), Wheeler et al.
patent: 6534048 (2003-03-01), Borgman
patent: 2002/0197300 (2002-12-01), Schultz et al.
patent: 2003/0068343 (2003-04-01), Muizzuddin et al.
patent: 2003/0077301 (2003-04-01), Maibach et al.
patent: 2003/0087962 (2003-05-01), Demopulos et al.
patent: 2003/0229088 (2003-12-01), Gil et al.
patent: 2004/0092482 (2004-05-01), Gupta
patent: 2004/0156873 (2004-08-01), Gupta
patent: 2004/0220259 (2004-11-01), Yu et al.
patent: 2004/0242588 (2004-12-01), Dejovin et al.
patent: 2004/0254252 (2004-12-01), Engles et al.
patent: 2004/0266776 (2004-12-01), Gil et al.
patent: 2005/0020600 (2005-01-01), Scherer
patent: 2005/0165079 (2005-07-01), Shanler et al.
patent: 1381979 (1975-01-01), None
patent: WO 96/25163 (1996-08-01), None
patent: WO 98/36730 (1998-08-01), None
patent: WO 00/76502 (2000-12-01), None
Wymenga, A.N. et al., Management of Hot Flushes in Breast Cancer Patients, Acta Ocologica, 2002, vol. 41, No. 3, pp. 269-275.
Scruggs, Jennifer T., et al., The Teardrop Sign: a Rare Dermatological Reaction to Brimonidine,Br J Ophthalmol, Jun. 2000, V. 84, pp. 671-672.
Sakakibara, R. et al., Treatment of Primary Erythromelalgia with Cyproheptadine,Journal of the Autonomic Nervous System, V. 58, Nos. 1+2, Apr. 20, 1996, pp. 121-122.
Jeyara, J., Selvi C., et al., Cooling Evokes Redistribution of α2c-Adrenoceptors from Golgi to Plasma Membrane in Transfected Human Embryonic Kidney 293 Cells,Molecular Pharmacology, V. 60, No. 6, Dec. 2001, pp. 1195-1200.
Fuchs, Perry N., et al., Heat, but not Mechanical Hyperalgesia, following Adrenergic Injections in Normal Human Skin,Pain, V. 90, Nos. 1-2, Feb. 1, 2001, pp. 15-23.
Morrison, Shaun F., et al., Adrenergic Modulation of a Spinal Sympathetic Reflex in the Rat,J. Pharmacol. Experim. Therap., V. 273, No. 1, 1995, pp. 380-385.
Yaksh, Tony Y., et al., Reversal of Nerve Ligation-Induced Allodynia by SpinalAlpha-2 Adrenoceptor Agonists,J. Pharmacol. Experim. Therap., V. 272, No. 1, 1995, pp. 207-214.
Waldron, C.J., et al., Relative Contribution of Different Vascular Beds to the Pressor Effects of α-Adrenoceptor Agonists and Vasopressin in Pithed Rats: Radioactive Microsphere Determination,J. Auton. Pharmac., 1985, V. 5, pp. 333-338.
Bockman et al. “Binding and Functional Characterization of Alpha-2-Adrenergic Receptor Subtypes on Pig Vascular Endothelium,” J. Pharmacol. Exp. Therapeutics, 1993, vol. 267, pp. 1126-1133.
Burke and Schwartz, “Preclinical Evaluation of Brimonidine,” Survey of Ophthalmology, 1996, vol. 41, pp. S9-S18.
Chein et al., “Corneal and conjuctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes,” Current Eye Research, 1990, vol. 9, No. 11, pp. 1051-1059.
Chotani et al. “Silent αsc-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries,” Am. J. Physiol. Heart Circ. Physiol., 2000, vol. 278, pp. H1075-H1083.
Freedman and Blacker, “Estrogen raises the sweating threshold in postmenopausal women with hot flashes,” Fertility and Sterility, 2002, vol. 77, No. 3, pp. 487-490.
Guarrera et al., “Flushing in Rosacea: A Possible Mechanism,” Arch. Dermatol. Res. 1982, vol. 272, pp. 311-316.
Nakamura and Ferreira, “Peripheral analgesic action of clonidine: mediation by release of endogenous enkephlin-like substances,” European Journal of Pharmacology, 1988, vol. 146, pp. 223-228.
Nielsen et al., “Postjunctional α2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels,” Br. J. Pharmacol., 1989, vol. 97, pp. 829-834.
Walters, “Development and Use of Brimonidine in Treating Acute and Chronic Elevations of Intraocular Pressure: A Review of Safety, Efficacy, Dose Response, and Dosing Studies,” Survey of Ophthalmology, 1996, vol. 41, pp. S19-S26.
Wilkin, “Effect of Subdepressor Clonidine on Flushing Reactions in Rosacea,” Arch. Dermatol., 1983, vol. 119, pp. 211-214.
Wilkin, “Why is flushing limited to a mostly facial cutaneous distribution?” J. Am. Acad. Dermatol., 1988, vol. 19, pp. 309-313.
Amdt et al., Manual of Dermatologic Therapeutics 7th ed., 176-177, (2007).
Cunliffe et al., Br. Med. J. 105 (Jan. 8, 1977).
Shanler et al., Arch Dermatol, 143(11):1369-1371(Nov. 2007).
Wilkin et al., J. Am. Acad. Dermatol. 46:584-587 (2002).
Webster, Guy F., “Rosacea and related disorders” Dermatology, J. Bolognia, J. Jorizzo, R. Rapini eds, vol. 1, Chpt. 39, pp. 545-552 (2003).

Affiliated with

Also associated with

Rating

Compounds, formulations, and methods for treating or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, formulations, and methods for treating or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, formulations, and methods for treating or... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4010844